Charles Schwab
OFIX icon

Charles Schwab’s Orthofix Medical OFIX Stock Holding History

Charles Schwab’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
334,617
+8,874
+3% +$97.8K ﹤0.01% 2648
2026
Q1 		$3.74M Sell
325,743
-8,062
-2% -$106K ﹤0.01% 2517
2025
Q4 		$5.06M Sell
333,805
-1,993
-0.6% -$30.4K ﹤0.01% 2452
2025
Q3 		$4.92M Buy
335,798
+54,713
+19% +$718K ﹤0.01% 2449
2025
Q2 		$3.13M Sell
281,085
-43,762
-13% -$542K ﹤0.01% 2518
2025
Q1 		$5.3M Sell
324,847
-14,684
-4% -$258K ﹤0.01% 2249
2024
Q4 		$5.93M Buy
339,531
+14,724
+5% +$256K ﹤0.01% 2261
2024
Q3 		$5.07M Buy
324,807
+39,901
+14% +$639K ﹤0.01% 2373
2024
Q2 		$3.78M Buy
284,906
+1,284
+0.5% +$17.6K ﹤0.01% 2476
2024
Q1 		$4.12M Sell
283,622
-178,263
-39% -$2.46M ﹤0.01% 2352
2023
Q4 		$6.23M Buy
461,885
+32,400
+8% +$381K ﹤0.01% 2213
2023
Q3 		$5.52M Buy
429,485
+20,535
+5% +$369K ﹤0.01% 2206
2023
Q2 		$7.39M Buy
408,950
+17,879
+5% +$334K ﹤0.01% 2053
2023
Q1 		$6.55M Buy
391,071
+122,575
+46% +$2.4M ﹤0.01% 2077
2022
Q4 		$5.51M Buy
268,496
+20,336
+8% +$359K ﹤0.01% 2163
2022
Q3 		$4.74M Buy
248,160
+21,562
+10% +$485K ﹤0.01% 2237
2022
Q2 		$5.33M Buy
226,598
+15,866
+8% +$454K ﹤0.01% 2161
2022
Q1 		$6.89M Buy
210,732
+11,531
+6% +$370K ﹤0.01% 2129
2021
Q4 		$6.19M Buy
199,201
+11,626
+6% +$389K ﹤0.01% 2244
2021
Q3 		$7.15M Buy
187,575
+8,550
+5% +$340K ﹤0.01% 2203
2021
Q2 		$7.18M Buy
179,025
+10,527
+6% +$445K ﹤0.01% 2176
2021
Q1 		$7.3M Buy
168,498
+42,924
+34% +$1.89M ﹤0.01% 2112
2020
Q4 		$5.4M Buy
125,574
+631
+0.5% +$23.1K ﹤0.01% 2179
2020
Q3 		$3.89M Sell
124,943
-625
-0.5% -$19.4K ﹤0.01% 2201
2020
Q2 		$4.02M Buy
125,568
+9,004
+8% +$299K ﹤0.01% 2128
2020
Q1 		$3.27M Sell
116,564
-40,723
-26% -$1.58M ﹤0.01% 2051
2019
Q4 		$7.26M Buy
157,287
+15,595
+11% +$733K ﹤0.01% 1831
2019
Q3 		$7.51M Buy
141,692
+14,357
+11% +$741K ﹤0.01% 1767
2019
Q2 		$6.73M Sell
127,335
-45,033
-26% -$2.4M ﹤0.01% 1829
2019
Q1 		$9.72M Buy
172,368
+11,463
+7% +$643K 0.01% 1609
2018
Q4 		$8.45M Sell
160,905
-452
-0.3% -$25.7K 0.01% 1563
2018
Q3 		$9.33M Buy
161,357
+10,447
+7% +$585K 0.01% 1686
2018
Q2 		$8.57M Buy
150,910
+24,050
+19% +$1.37M 0.01% 1702
2018
Q1 		$7.46M Buy
126,860
+2,793
+2% +$156K 0.01% 1699
2017
Q4 		$6.79M Buy
124,067
+7,673
+7% +$398K 0.01% 1747
2017
Q3 		$5.5M Sell
116,394
-13,666
-11% -$644K ﹤0.01% 1830
2017
Q2 		$6.05M Sell
130,060
-39,083
-23% -$1.62M 0.01% 1693
2017
Q1 		$6.45M Buy
169,143
+4,428
+3% +$164K 0.01% 1603
2016
Q4 		$5.96M Buy
164,715
+47,337
+40% +$1.8M 0.01% 1621
2016
Q3 		$5.02M Buy
117,378
+49,569
+73% +$2.21M 0.01% 1650
2016
Q2 		$2.88M Sell
67,809
-28,351
-29% -$1.23M ﹤0.01% 1898
2016
Q1 		$3.99M Buy
96,160
+2,537
+3% +$99.5K 0.01% 1655
2015
Q4 		$3.67M Sell
93,623
-1,132
-1% -$42.3K ﹤0.01% 1718
2015
Q3 		$3.2M Buy
94,755
+13,585
+17% +$484K ﹤0.01% 1766
2015
Q2 		$2.69M Buy
81,170
+4,736
+6% +$163K ﹤0.01% 1930
2015
Q1 		$2.74M Sell
76,434
-760
-1% -$23.9K ﹤0.01% 1884
2014
Q4 		$2.32M Buy
77,194
+6,401
+9% +$188K ﹤0.01% 1923
2014
Q3 		$2.19M Buy
70,793
+19,457
+38% +$646K ﹤0.01% 1921
2014
Q2 		$1.86M Buy
51,336
+4,729
+10% +$153K ﹤0.01% 2016
2014
Q1 		$1.41M Buy
46,607
+1,200
+3% +$27.7K ﹤0.01% 2124
2013
Q4 		$1.04M Buy
45,407
+1,440
+3% +$30.1K ﹤0.01% 2250
2013
Q3 		$924K Sell
43,967
-1,660
-4% -$40.3K ﹤0.01% 2248
2013
Q2 		$1.25M Buy
+45,627
New +$1.37M ﹤0.01% 2028

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab's OFIX Position: Q2 2026 in Review

Charles Schwab increased its Orthofix Medical (OFIX) stake by 2.7% in Q2 2026, buying an estimated $97.8K and bringing the position to 334,617 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

Charles Schwab first reported a position in OFIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.72M in Q1 2019. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Charles Schwab held 334,617 shares of Orthofix Medical worth $3.06M as of Q2 2026.
  • Charles Schwab bought 8,874 Orthofix Medical shares in Q2 2026, an estimated $97.8K.
  • Orthofix Medical made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2648 holding.
  • Charles Schwab first reported a position in Orthofix Medical in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Orthofix Medical position peaked at $9.72M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.